---
title: "Firefly Neuroscience, Inc. (AIFF.US)"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/AIFF.US.md"
symbol: "AIFF.US"
name: "Firefly Neuroscience, Inc."
industry: "Health Care Technology"
datetime: "2026-05-02T04:56:24.518Z"
locales:
  - [en](https://longbridge.com/en/quote/AIFF.US.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/AIFF.US.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/AIFF.US.md)
---

# Firefly Neuroscience, Inc. (AIFF.US)

## Company Overview

Firefly Neuroscience, Inc., a medical technology and artificial intelligence company, provides neuroscientific solutions that improve brain health outcomes for patients with mental illnesses and neurological disorders in the United States. The company offers Brain Network Analytics, a software that focuses on diagnostic and treatment for people suffering from mental illnesses and cognitive disorders, including depression, dementia, anxiety disorders, concussions, parkinson's disease, bipolar disorder, schizophrenia, schizoaffective disorder, mild cognitive impairment, post-traumatic stress disorder, and traumatic brain injury and attention-deficit/hyperactivity disorder. It serves pharmaceutical companies and medical practitioners. Firefly Neuroscience, Inc.

| Item | Detail |
|------|--------|
| Industry | Health Care Technology |
| Exchange | US Market |
| Website | [fireflyneuro.com](https://fireflyneuro.com) |

## Key Drivers
> *AI-analyzed key factors driving this stock's performance*


## Longbridge Financial Score™: C
> *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge*
> Updated: 2026-05-01T04:30:18.000Z

**Overall: C (0.47)**

**Industry**: Health Care Technology

| Metric | Value |
|--------|-------|
| Industry Ranking | 25 / 48 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Blend - Stocks in which the company has both growth and mature businesses.
- **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns.

**Multi Score**: C

#### Style Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | 957.41% |  |
| Net Profit YoY | -134.52% |  |
| P/B Ratio | 4.34 |  |
| Dividend Ratio | 0.00% |  |

#### Size Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 33136488.00 |  |
| Revenue | 1142000.00 |  |

#### Multi Score Score: C

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | -675.60% | E |
| Profit Margin | -1740.98% | E |
| Gross Margin | 56.48% | B |
| Revenue YoY | 957.41% | A |
| Net Profit YoY | -134.52% | E |
| Total Assets YoY | 127.71% | A |
| Net Assets YoY | 2136.53% | A |
| Cash Flow Margin | 33.40% | C |
| OCF YoY | 957.41% | A |
| Turnover | 0.15 | D |
| Gearing Ratio | 27.11% | B |

```chart-data:radar
{
  "title": "Longbridge Financial Score - Firefly Neuroscience, Inc.",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Style Score",
      "grade": "",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "957.41%",
          "rating": ""
        },
        {
          "name": "Net Profit YoY",
          "value": "-134.52%",
          "rating": ""
        },
        {
          "name": "P/B Ratio",
          "value": "4.34",
          "rating": ""
        },
        {
          "name": "Dividend Ratio",
          "value": "0.00%",
          "rating": ""
        }
      ]
    },
    {
      "name": "Size Score",
      "grade": "",
      "indicators": [
        {
          "name": "Market Cap",
          "value": "33136488.00",
          "rating": ""
        },
        {
          "name": "Revenue",
          "value": "1142000.00",
          "rating": ""
        }
      ]
    },
    {
      "name": "Multi Score",
      "grade": "C",
      "indicators": [
        {
          "name": "ROE",
          "value": "-675.60%",
          "rating": "E"
        },
        {
          "name": "Profit Margin",
          "value": "-1740.98%",
          "rating": "E"
        },
        {
          "name": "Gross Margin",
          "value": "56.48%",
          "rating": "B"
        },
        {
          "name": "Revenue YoY",
          "value": "957.41%",
          "rating": "A"
        },
        {
          "name": "Net Profit YoY",
          "value": "-134.52%",
          "rating": "E"
        },
        {
          "name": "Total Assets YoY",
          "value": "127.71%",
          "rating": "A"
        },
        {
          "name": "Net Assets YoY",
          "value": "2136.53%",
          "rating": "A"
        },
        {
          "name": "Cash Flow Margin",
          "value": "33.40%",
          "rating": "C"
        },
        {
          "name": "OCF YoY",
          "value": "957.41%",
          "rating": "A"
        },
        {
          "name": "Turnover",
          "value": "0.15",
          "rating": "D"
        },
        {
          "name": "Gearing Ratio",
          "value": "27.11%",
          "rating": "B"
        }
      ]
    }
  ]
}
```

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -1.37 | 25/48 | - | - | - |
| PB | 4.40 | 26/48 | 7.24 | 2.99 | 1.66 |
| PS (TTM) | 29.40 | 33/48 | 278.58 | 58.76 | 20.47 |
| Dividend Yield | 0.00% | - | - | - | - |

## Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 01 | QHSLab, Inc. (USAQ.US) | A | A | A | B | B | A |
| 02 | Veeva Systems -CL (VEEV.US) | A | B | C | A | B | B |
| 03 | Doximity (DOCS.US) | A | B | C | A | B | B |
| 04 | Waystar (WAY.US) | B | A | D | B | A | B |
| 05 | HeartFlow (HTFL.US) | B | B | B | A | B | B |

## References

- [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/AIFF.US/overview.md)
- [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/AIFF.US/norm.md)
- [Related News](https://longbridge.com/en/quote/AIFF.US/news.md)
- [Filings — Company announcements and regulatory filings](https://longbridge.com/en/quote/AIFF.US/filings.md)

---

> **Disclaimer: This article is for reference only and does not constitute any investment advice.**